17 community organizations have been selected to receive funding through the Boston Children’s Collaboration for Community Health. 👏 This round of funding was in the Birth to Five Child Health and Development Initiative. A total of $5.9 million has been awarded for use over the next four years. These funded projects are supporting community partners in their efforts to improve the health and well-being of children from birth to five years of age. More info here: http://ms.spr.ly/6043liKac
Boston Children's Hospital
Hospitals and Health Care
Boston, MA 154,650 followers
Where the world comes for answers.
About us
Boston Children's Hospital is a 404-bed comprehensive center for pediatric health care. As one of the largest pediatric medical centers in the United States, Boston Children's offers a complete range of health care services for children from birth through 21 years of age. (Our services can begin interventions at 15 weeks gestation and in some situations we also treat adults.) We have approximately 25,000 inpatient admissions each year and our 200+ specialized clinical programs schedule 557,000 visits annually. Last year, the hospital performed more than 26,500 surgical procedures and 214,000 radiological examinations. Our team of physicians and nurses has been recognized by a number of independent organizations for overall excellence, and we're proud to share some notable examples with you here.
- Website
-
http://www.childrenshospital.org
External link for Boston Children's Hospital
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Boston, MA
- Type
- Nonprofit
- Founded
- 1869
- Specialties
- Research, Patient Services, Technology, Pediatrics, Hospital, and Innovation
Locations
Employees at Boston Children's Hospital
-
Andreas Ramos
Author of 22+ books on digital marketing | Adjunct Professor | Teach university-level AI-powered digital marketing at Omnes, CSTU, DMAnc | Graduate,…
-
Chris Newell
Senior Director Organizational Development at Boston Children's Hospital
-
Walter Pressey
Independent Director, Forsyth Institute
-
Michael Edson
IT Manager, Virtual Care and DH Emerging Tech
Updates
-
Exciting News from the Department of Neurology! We are delighted to announce the appointment of Mustafa Sahin, MD, PhD, as the new neurologist-in-chief and chair of the Department of Neurology, succeeding Scott Pomeroy, MD, PhD, after his nearly 20 years of exceptional leadership. 👏 Dr. Sahin is renowned for his groundbreaking work in the neurobiology of autism and translational studies for neurogenetic disorders, particularly Tuberous Sclerosis Complex (TSC). His research has identified critical mechanisms underlying neuron mis-wiring in TSC, paving the way for potential therapeutic breakthroughs. Join us in congratulating Dr. Sahin on his new role and expressing our heartfelt thanks to Dr. Pomeroy for his incomparable service to pediatric neurology. Dr. Pomeroy will remain a member of our Neurology faculty, continuing his research projects, academic and teaching activities, and caring for patients at Boston Children’s for the foreseeable future. #PediatricNeurology #BostonChildrens #LeadershipAnnouncement
-
-
During the COVID-19 pandemic, mRNA vaccines came to the rescue, developed in record time and saving lives worldwide. David Dowling, Ph.D. and Byron Brook in the Precision Vaccines Program led the development of two novel technologies that could make mRNA vaccines stronger and longer-lasting — at smaller doses and with fewer side effects. Learn more about their work, published in Science Translational Medicine. 👇
A shot in the arm for mRNA vaccines? - Boston Children's Answers
https://answers.childrenshospital.org
-
The lab of Chris Walsh of Boston Children’s and the The Paul G. Allen Frontiers Group Discovery Center for Human Brain Evolution, has found that a third or more of the fastest-evolving regions of the human genome (known as human accelerated regions or HARs) are active during brain development, and that mutations in HARs contribute to autism among families with shared ancestry. Walsh, Ryan Doan, Ph.D., DABMGG, FACMG Taehwan Shin, Janet Song and other colleagues now extend the HARS–autism link in a larger cohort of smaller families with more diverse ancestry, mainly from the U.S. They also find that mutations in non-coding regions of the genome contribute to autism risk as well. 👇
Rare variation in non-coding regions with evolutionary signatures contributes to autism spectrum disorder risk
cell.com
-
Kudos to the research teams for advancing the science around progeria! Boston Children’s is proud to have been part of the #progeria story. Starting in 2007, we hosted a clinical trial of a drug called lonafarnib, welcoming children with progeria from all over the world – three-quarters of all those known at the time. Lonafarnib began as an experimental cancer drug and targets the same molecule as the gene editing therapy (lamin A). The trial showed that it extends patients’ lives by an average of 2.5 years, and many patients had improved heart health and weight gain. The FDA approved lonafarnib in 2020 under the name of Zokinvy. More of this history here: http://ms.spr.ly/6046lX9XE
A Disease That Makes Children Age Rapidly Gets Closer to a Cure
https://www.nytimes.com
-
How far did families need to travel to get their children COVID-19 shots? These maps, with July 2022 data from > 27,000 vaccination sites, tell part of the story. Rural children, especially those under 5, often had to travel 2+ hours to get vaccinated. Overall, rural, uninsured, white, and Native American populations had longer travel times than urban, insured, Hispanic, Black, and Asian American populations. Rohan Khazanchi, MPH et al. hope their findings will help authorities prioritize resource allocation in future outbreaks — with the help of their Vaccine Equity Planner (http://ms.spr.ly/6047lVssP). 👇
Spatial Accessibility and Uptake of Pediatric COVID-19 Vaccinations by Social Vulnerability
publications.aap.org
-
Go, team! 👏 Members of our Brain Tumor Center recently attended the 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) in Philadelphia, where they shared recent research findings with colleagues from around the world. Special thanks to everyone who participated, including (pictured left to right) Nicole Ullrich, MD, PhD; Mimi Bandopadhayay, MBBS, PhD; Susan Chi, MD; and Aaron Yeo, MD — the latter of which served as an Education Day co-lead on the symposium’s Organizing Committee.
-
-
We had a great time welcoming colleagues to Boston Children’s for a hands-on, immersive fetal therapy simulation during ISPD 2024. 👏 Attendees tried out our high-fidelity surgery simulators developed by our Maternal Fetal Care Center and Immersive Design Systems. Simulated procedures included fetoscopic laser for twin-twin transfusion syndrome, fetoscopic tracheal occlusion, and fetoscopic spina bifida repair. International Society for Prenatal Diagnosis http://ms.spr.ly/6043lVseT http://ms.spr.ly/6044lVsep
-